Introduction
With the introduction of methods of rapid nucleic acid sequence determination, synthesis of mixed oligonucleotide probes and computer-assisted analysis of nucleic 100 NC-IUB acid sequences, the use of a single symbol to designate a variety of possible nucleotides at a single position has become widespread over the last few years. Whereas the use of, for example, the symbols R and Y to designate purine (A or G) and pyrimidine (C or T) ribonucleotides respectively [l] is generally accepted, no agreed symbols exist for the other possible combinations. Indeed, a plethora of diverse systems has proliferated in the last few years [2-l I] . It is striking that, in one extreme case, the combination (C or G) has been represented by at least five different symbols [2-4, 8, 111 . A standardized set of symbols is thus required to prevent confusion.
The symbols are intended to be applicable to both deoxyribonucleic and ribonucleic acids. Thus it is important to note from the outset that the recommended symbols will not discriminate between DNA and RNA, and the symbol T will be employed at all positions where U might appear in the RNA. Similarly, no distinction will be made in the symbols between base, nucleoside and nucleotide. Sequences may be assumed to have a deoxyribose backbone (DNA) unless specified otherwise. These changes from earlier recommendations [l] reflect great advances in techniques for sequencing DNA so that RNA sequences are now commonly deduced from the corresponding DNA sequences. Since the standard representation of a DNA sequence may be converted to the corresponding RNA sequence by the simple expedient of substituting T by U, it is not envisaged that data banks based on computer storage facilities will inevitably contain entries for both DNA and its RNA equivalent. Authors should always, however, make it clear which strand of DNA or RNA a given sequence refers to, and in circumstances where confusion between DNA and RNA is likely the sequence may be prefixed with the lower-case letter d or r, as in the previous recommendations [ 
11.
As the present recommendations present unique alphabetic symbols for each nucleotide combination, the use of upper-and lower-case letters as equivalent does not lead to confusion. However, such use may cause confusion between r (ribo-) and R (pm-me), and care must be taken in those rare cases where the various symbols are used in combination. In general, it should be emphasised (i) that upper-case symbols are advocated, and (iz) that the present recommendations are not intended to prejudice any possible future use of contrasting upper-and lower-case letters for specific purposes.
It was previously [I] recommended that hyphens should be used to represent phosphodiester linkages in known nucleotide sequences. As there is now little danger of confusion between codon triplets and nucleotide sequences this recommendation is no longer considered necessary. Hyphens may therefore be omitted from sequences, and are omitted from all sequences in this document. In addition it may be assumed that all sequences are presented 5' to 3' unless otherwise specified, although specific mention of this fact is not discouraged.
Although several diverse systems of symbols for incompletely specified bases already exist in the literature, this presentation makes no systematic review. Details of the previous recommendations may be found in [I] , and of systems that have been used in the literature in [2-111. 
Recognition Sequences in DNA for Other Enzymes
Restriction enzymes are highly specific for particular nucleic acid sequences. For many other enzymes the specificity is rather more lax, however, and the symbols are intended to meet in part the need for presenting a schematic summary of the sequence features. For instance, sequences recognised by the RNA polymerase of Escherichia coli may be presented as the juxtaposition of two sequences 5'-AA(A or T)NTNNN(C or G)TTGACA-3' and 5'-(T or G)NNTATAAT-3' separated by 13 to 16 nucleotides (adapted from [ 15, 16] ), where N represents any nucleotide. A similar treatment may be applied to the recognition sequences for other DNA binding proteins such as repressor molecules. 
Codon Degeneracy
Although there are 64 possible triplet codons, there are only 20 different amino acids coded by them. Thus most amino acids are inserted into a growing polypeptide chain in response to two or more different triplets in the mRNA ([ 191 for a general review). For example, proline is coded by 5'-CCN-3' and alanine by 5'-GCN-3'. In other cases the pattern may be more complex, such as for isoleucine, which is coded by 5'-AT(T, C or A)-3'. Note that certain amino acids (e.g. serine) may be coded by two distinct groups of triplets [here 5'-TCN-3' and 5'-AG(T or C)-3'1, which cannot be adequately represented as 5'-(T or A) (C or G)N-3' (see Table 4 ). It is to be noted that synthetic oligonucleotide probes for detecting protein-coding sequences often involve the preparation of 'mixed probes'. Here a mixture of two (or more) nucleotides is incorporated at a single position in the oligonucleotide to take account of the redundancy of the genetic code (for instance [20] ). It is anticipated that a single-letter code might be used to designate such mixtures.
Construction of Ancestral Sequences by Parsimony Procedures [2 l]
Where two descendants differ in nucleic acid sequence at a particular position (for instance A in one and G in the other), the putative ancestral sequence can be represented [ lo] using a single-letter code, in this case R. The symbols are intended to be useful for all purposes in which the exact identity of a nucleotide may vary. Thus uncertainties encountered with primary nucleic acid sequence data may, in some cases, be represented using standard symbols.
Allocation of Symbols
In the choice of symbols the following considerations have been taken into account: (i) conformity to previous IUPAC-IUB nomenclature [ 11; (iz) logical derivation; (iii) ease of memorisation; (iv) availability of symbols on a standard typewriter keyboard; (v) historical precedence.
3.1. Guanine, Adenine, Thymine, Cytosine: G, A, T, C These one-letter symbols have previously been established [l] and are generally used. There is, however, a problem of discriminating between the upper-case letters G and C on poorly copied sequences. Nevertheless, the use of alternative symbols for G (such as a barred-G, G) is not recommended. Discrimination between the lowercase letters is much clearer. Note that T and U may, in general, be considered as being synonyms, though care should be taken to avoid ambiguity in circumstances where it is likely, e.g. in discussing artificial hybrids of DNA and RNA and in cases where specific distinction between T and U is advisable. thus be H); W derives from the strength of the hydrogen bonding interaction between the base pairs (weak for A + T: G + C-strong-would thus be S). However, the system recommended for the threebase series (not-A = B, etc., see below, section 3.8) rules out H as this would be not-G. W is thus recommended.
Guanine or Cytosine: S
The choice of this symbol is discussed above in section 3.4. 
Adenine or Thymine or Cytosine: H
Not-G is the most simple means of memorising this combination and symbols logically related to G were examined. F and H would both be suitable, as the letters before and after G in the alphabet, but A would have no equivalent to F. The use of H has historical precedence [2] .
Guanine or Cytosine or Thymine: B
Not-A as above (section 3.8).
3.10. Guanine or Adenine or Cytosine: V Not-T by analogy with not-G (section 3.8) would be U but this is ruled out to eliminate confusion with uracil. V is the next logical choice. Note that T and U may in some cases be considered to be synonyms. Occasionally it may be desirable to distinguish between unspecified (N) and unknown (X), but if X is used for this purpose it should be explicitly defined.
Other Accessory Symbols
There are a number of instances in which additional symbols may be required for routine work. Although this section provides a number of suggestions, these do not form part of the present recommendations.
First, we consider the uncertainty as to whether a base exists at a certain position or not. A symbol denoting 'G or A or T or C or no nucleotide', for example '?' or '+', might be used to define regions of uncertainty of limited variable size in a recognition sequence (see for instance [22] ). Alternatively, one of these symbols might be used as a modifier to denote uncertainty:
'?A' might, for instance, denote 'A or no nucleotide at this position'. Second, the unambiguous absence of a nucleotide introduced into a sequence for alignment or comparison purposes alone could be represented by ':', though a simple space has much to recommend itself. Third, a specified number of unknown nucleotides might be represented by a symbol such as '=' in conjunction with numerals, so that, for example, '=300=' might denote the presence of 300 unknown nucleotides. Fourth, the symbol 'N' (unknown or unspecified) may be replaced by the hyphen '-' in circumstances where rapid visual discrimination between 'known' (essential) and 'unknown' (non-essential) sequences is desirable. The value of this may be judged by comparing 'NNNNNCNNGNTNN'
with '-----C--G-T--', for example. Note that the use of the lower-case letter n may avoid the necessity for an additional symbol, as in 'nnnnnCnnGnTnn'.
In addition, the use of the oblique or slash '/' may present advantages in the definition of the precise cleavage sites of restriction endonucleases.
For instance, the cleavage specificity of the common enzyme EcoRI might be represented by G/AATTC, where cleavage occurs in both strands of the self-symmetrical sequence between the G and A residues.
It is emphasised that the symbols appearing in this section do no form an integral part of the recommendations and must therefore be defined explicitly in the context in which they are used. 
' In certain cases the symbol and its complement are identical.
Discussion
The present nomenclature, summarised in ' The sequence of amino acids is uniquely specified by the nucleotide sequence. Similarly, it is possible to convert an amino-acid sequence to a linear order of base uncertainties, but this raises problems with the codons for leucine, arginine, serine and termination. With leucine, for example, the coding triplets are precisely specified by GIN and TTR, but combining these gives YTN, which also includes two phenylalanine codons, TTT and TTC. Thus information may be lost when an amino-acid sequence is converted into a single sequence of base-uncertainty symbols. To avoid ambiguity, therefore, it is important to make it clear whenever the triplet YTN, for example, occurs in a sequence deduced from the occurrence of a leucine residue in the corresponding amino acid sequence that it does not include TTT or TTC as possibilities, etc. To emphasise this, it may be helpful to print such triplets in italics.
Interpretation of Primary Sequencing Data
In certain cases the nomenclature permits uncertainty encountered in nucleic acid sequencing to be represented using a single letter code. At least two applications, namely 'either X or XY' and 'probably X', are not adequately handled. Specialised nomenclatures have been developed specifically for such purposes (for instance [3] ).
Modified Nucleotides
In a number of organisms DNA and RNA are modified at certain positions. For instance, the DNA of Escherichia coli is usually methylated on N-6 of the adenine residue in the sequence S-GATC-3' [23] . The present nomenclature does not allocate any specific symbol to these modified nucleotides for the following reasons. (1) The presence or absence of a given modification depends upon the location of the DNA.
